VestGen Investment Management Grows Stock Holdings in UnitedHealth Group Incorporated $UNH

VestGen Investment Management raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.0% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 723 shares of the healthcare conglomerate’s stock after buying an additional 105 shares during the quarter. VestGen Investment Management’s holdings in UnitedHealth Group were worth $226,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Citizens National Bank Trust Department lifted its position in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after buying an additional 170 shares during the last quarter. Caitlin John LLC increased its holdings in shares of UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Triumph Capital Management purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $1,324,000. Wealth Effects LLC raised its position in shares of UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock valued at $1,463,000 after purchasing an additional 591 shares during the last quarter. Finally, Arlington Partners LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $2,229,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on UNH shares. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. The Goldman Sachs Group started coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They issued a “buy” rating and a $406.00 price target on the stock. Finally, Robert W. Baird reiterated an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $385.13.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $362.78 on Monday. The stock has a market capitalization of $328.56 billion, a price-to-earnings ratio of 15.72, a PEG ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm’s 50 day simple moving average is $338.43 and its 200-day simple moving average is $335.78. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the previous year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.